Spinal Trauma

3

Review clinical trials related to Spinal Trauma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Ailliance Post-Market Clinical Study

The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medtronic Spinal and BiologicsUpdated: Jun 30, 2026Locations: 28
Eligibility criteria

Subject provides written informed consent per institution and/or geographical re... [+3]

Subject is currently enrolled or plans to enroll in concurrent drug/device/biolo... [+3]

Status: Recruiting

PMCF Study on the Effectiveness and Safety of METROSAN Spinal Systems and BONEGRAFT Filling Materials

This is a prospective, multi-center, observational Post-Market Clinical Follow-Up (PMCF) study designed to collect additional safety and clinical performance data on CE-marked Titania® spinal instrumentation and fusion systems, and Bonegraft® bone filling materials (synthetic bone grafts and bone cements). The study aims to evaluate short-term (12-month) safety and effectiveness, identify previously unknown side effects, monitor defined complications, and assess risks based on real-world evidence in patients undergoing spinal surgery. All investigated products are used within their intended purpose under routine clinical practice.

Participants needed: 561
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Metrosan End. ve Elk. Mek. Cihazlar ve Tibbi Malz. San. Tic. Ltd. Co.Updated: May 29, 2026Locations: 3
Eligibility criteria

18 years of age or older. [+7]

Participation in another interventional clinical investigation [+10]

Status: Not yet recruiting

The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery

Postoperative delirium is a delirium that occurs within 7 days after surgery or before hospital discharge. It has been shown that combined POD can increase the incidence of postoperative pulmonary infections, deep vein thrombosis and decubitus ulcers, and increase the incidence of disability and mortality. The incidence of postoperative delirium in geriatric orthopedics is high. Investigators conduct a prospective clinical study on geriatric orthopedic surgery patients to investigate the effect of oxytocin nasal spray on the prevention of postoperative delirium in geriatric orthopedic surgery. Cases were included according to the inclusion and exclusion criteria, and induction, maintenance and resuscitation were performed according to the standard protocol for general anesthesia. Before the end of surgery, the Investigators administered oxytocin nasal spray (Oxytocin) that was 3 sprays in each nostril (4 IU each) for a total of 24 IU. Beginning 1 day postoperatively, administer 24 IU of oxytocin nasal spray 2 times/day in the morning and in the evening. Until 7 days after surgery or discharge. The sample size are 77 cases in phase I and 143 cases in phase 2, total 220 cases.

Participants needed: 220
Trial details
Phase: Phase 2Age: 65+Biological sex: AllType: InterventionalSponsor: Zhejiang UniversityUpdated: May 25, 2025Locations: 1
Eligibility criteria

Age ≥ 65 years; [+5]

Nasal cavity occupation, patients with fillers in the nose [+12]